FGL1 and familial pancreatic carcinoma: Thus, in this study, we investigated both the expression and the role of HPS in KRAS-mutated PDAC cell lines, and we analyzed lipidomic differences, including n-3 and n-6 PUFAs, in HPS-knockdown pancreatic cancer cells.